Press Releases Choose Year All Items 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Search Press Releases Found 269 Results June 23, 2020 Relmada Therapeutics Announces Notice of Allowance for Patent in Canada Covering REL-1017 for Treatment of Psychiatric Symptoms June 9, 2020 Relmada Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference May 29, 2020 Relmada Therapeutics to Present at the Jefferies 2020 Virtual Healthcare Conference May 27, 2020 Relmada Therapeutics Announces Outcome of End-of-Phase 2 Meeting with FDA for REL-1017 for Adjunctive Treatment of Patients with Major Depressive Disorder May 26, 2020 Relmada Therapeutics Appoints Molly Harper as Executive Vice President of Operations April 28, 2020 Relmada Therapeutics Enhances Senior Leadership Team with Appointment of Brian A. Walter, Ph.D., as Vice President of Regulatory Affairs March 31, 2020 Relmada Therapeutics Solidifies its R&D Leadership Team with the Appointment of Marc de Somer, MD, MBA, ScD, MPH, MSc, as Senior Vice President, Clinical Development and Safety March 24, 2020 Relmada Therapeutics Strengthens Scientific Leadership Team with the Appointment of Judy Caron, Ph.D., as Vice President of Drug Development March 9, 2020 Relmada Therapeutics Appoints CNS Specialist Thomas C. Wessel, M.D., Ph.D., as Executive Vice President, Head of Research and Development February 25, 2020 Relmada Therapeutics to Present at 9th Annual SVB Leerink Global Healthcare Conference «...121314151617...»
